Back

The BinaxNOW antigen detection assay on CSF samples for diagnosis of pneumococcal meningitis

Peela, S. C. M.; Sistla, S.

2023-01-07 infectious diseases
10.1101/2023.01.03.23284152 medRxiv
Show abstract

IntroductionThe BinaxNOW pneumococcal antigen detection assay is an immuno-chromatographic technique where the cell wall polysaccharide instead of capsular polysaccharide is the target. Although intended for use on urine samples, its role in diagnosis of pneumococcal meningitis has been reported by many others. The current study explores its accuracy when compared with real-time PCR. MethodologyCSF samples from suspected meningitis cases were processed for Gram stain and culture following standard protocols. Antigen was detected by BinaxNOW antigen detection assay for Streptococcus pneumoniae. Previously published primers and protocols were used for real-time PCR targeting autolysin (lytA) gene and was considered as the gold standard test. ResultsAmong the 74 samples tested, pneumococcal antigen was detected in 21.6% (16/74) and qPCR in 11 (14.9%) samples. Antigen detection assay had higher sensitivity (90.9%) when compared with culture (45.5%) while the positive predictive value was the lowest (62.5% and 100% for culture). It was in substantial agreement with the gold standard test with kappa coefficient of 0.685 and an accuracy of 90.5%. ConclusionsThe BinaxNOW pneumococcal antigen detection test can be employed for initial screening of samples or point-of-care test owing to its substantial agreement with real-time PCR.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.